Log In
Print
BCIQ
Print
Print this Print this
 

amphetamine XR-ODT (NT-0202)

Also known as: NT0202

  Manage Alerts
Collapse Summary General Information
Company Neos Therapeutics Inc.
DescriptionExtended-release, orally disintegrating tablet formulation of amphetamine polistirex.
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat ADHD
Regulatory Designation
Partner Shire plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today